Drug Type Prophylactic vaccine, Multivalent vaccine, mRNA vaccine |
Synonyms Quadrivalent Influenza mRNA Vaccine |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Influenza, Human | Phase 2 | Australia | 12 Dec 2022 | |
| Influenza, Human | Phase 2 | United States | 12 Dec 2022 | |
| Influenza, Human | Phase 2 | Puerto Rico | 12 Dec 2022 | |
| Vaccination | Phase 2 | United States | 12 Dec 2022 | |
| Vaccination | Phase 2 | Puerto Rico | 12 Dec 2022 | |
| Vaccination | Phase 2 | Australia | 12 Dec 2022 |





